Show Summary Details
Page of

Presentation and management of Alzheimer’s disease 

Presentation and management of Alzheimer’s disease
Presentation and management of Alzheimer’s disease

Susan Rountree

and Rachelle S. Doody

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 16 September 2021

This chapter reviews recent advances in the assessment and management of AD patients including the clinical use of biomarkers to detect beta- amyloid deposition and neuronal injury. Recommendation for the use of pharmacologic and non-pharmacologic therapies is discussed. Clinical vignettes are provided to illustrate the various stages of AD dementia and to highlight amnestic versus non-amnestic presentations of this disorder. Overviews of emerging and future therapies along with results from recent trials involving investigational therapeutics are provided. We have reached the milestone of technological advances that can now detect preclinical AD which will ultimately lead to strategies that will modify or prevent clinical disease progression in the near future.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.